NASDAQ:GBSNGreat Basin Scientific Stock Price, Forecast & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Great Basin Scientific Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume104,097 shsAverage Volume99,205 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious diseases, especially hospital-acquired infections. Its commercially available tests are clostridium difficile (C. diff) and Group B Strep. Its system includes an analyzer and a diagnostic cartridge. Each analyzer contains a module into, which individual test cartridges are placed. Its other diagnostic assays in the late stages of product development include a pre-surgical nasal screen for Staphylococcus aureus (SA), food borne pathogen panel, panel for candida blood infections, test for pertussis and a test for Chlamydia tracomatis (CT)/Neisseria gonorrhea (NG). The Company also has a pipeline of assays in an early stage of development, including respiratory testing and sepsis (blood infection) panels. It markets a platform of molecular testing in small to medium sized hospitals.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Great Basin Scientific. Previous Next 2.4 Community Rank Outperform VotesGreat Basin Scientific has received 131 “outperform” votes. (Add your “outperform” vote.)Underperform VotesGreat Basin Scientific has received 137 “underperform” votes. (Add your “underperform” vote.)Community SentimentGreat Basin Scientific has received 51.12% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Great Basin Scientific and other stocks. Vote “Outperform” if you believe GBSN will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GBSN will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldGreat Basin Scientific does not currently pay a dividend.Dividend GrowthGreat Basin Scientific does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Great Basin Scientific insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.48 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry N/A Sub-IndustryN/A SectorN/A Current SymbolNASDAQ:GBSN Previous Symbol CUSIPN/A CIK1512138 Webgbscience.com Phone+1-801-9901055Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive GBSN News and Ratings via Email Sign-up to receive the latest news and ratings for GBSN and its competitors with MarketBeat's FREE daily newsletter. Great Basin Scientific (NASDAQ:GBSN) Frequently Asked Questions How were Great Basin Scientific's earnings last quarter? Great Basin Scientific Inc (NASDAQ:GBSN) released its quarterly earnings results on Wednesday, March, 22nd. The medical research company reported ($18.25) earnings per share for the quarter. The medical research company earned $0.85 million during the quarter. View Great Basin Scientific's earnings history. When did Great Basin Scientific's stock split? How did Great Basin Scientific's stock split work? Great Basin Scientific's stock reverse split on the morning of Friday, September 16th 2016. The 1-80 reverse split was announced on Wednesday, September 14th 2016. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 15th 2016. An investor that had 100 shares of Great Basin Scientific stock prior to the reverse split would have 1 shares after the split. Has Great Basin Scientific been receiving favorable news coverage? News headlines about GBSN stock have trended extremely positive recently, according to InfoTrie Sentiment. The research group ranks the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Great Basin Scientific earned a media sentiment score of 5.0 on InfoTrie's scale. They also assigned news coverage about the medical research company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutGreat Basin Scientific. What other stocks do shareholders of Great Basin Scientific own? Based on aggregate information from My MarketBeat watchlists, some companies that other Great Basin Scientific investors own include Macrocure (MCUR), LinnCo (LNCOQ), California Resources (CRC), BreitBurn Energy Partners (BBEPQ), Ultra Petroleum (UPLMQ), VelocityShares Daily 2x VIX Short Term ETN (TVIX), U.S. Energy (USEG), Synergy Pharmaceuticals (SGYP), BioCryst Pharmaceuticals (BCRX) and Linn Energy (LINEQ). Who are Great Basin Scientific's key executives? Great Basin Scientific's management team includes the following people: David Spafford, Executive Chairman of the Board (Age 55)Robert Jenison, Senior Vice President - Research, Chief Technology Officer (Age 50)Ryan Ashton, President, Chief Executive Officer, Director (Age 56)Kirk K. Calhoun, Independent Director (Age 73)Sam Chawla, Independent Director (Age 41)Ronald K. Labrum, Independent Director (Age 60) What is Great Basin Scientific's stock symbol? Great Basin Scientific trades on the NASDAQ under the ticker symbol "GBSN." What is Great Basin Scientific's official website? The official website for Great Basin Scientific is gbscience.com. How can I contact Great Basin Scientific? Great Basin Scientific's mailing address is 420 E South Temple Ste 520, SALT LAKE CITY, UT 84111-1362, United States. The medical research company can be reached via phone at +1-801-9901055. This page was last updated on 5/27/2020 by MarketBeat.com Staff
